[Form 4] Gevo, Inc. Insider Trading Activity

Rhea-AI Filing Summary

On 08/01/2025, Gevo, Inc. (GEVO) Chief Advocacy & Communications Officer Lindsay Clinton Fitzgerald filed a Form 4 disclosing the sale of 5,185 common shares at a weighted-average price of $1.2529. The disposition was executed under a Rule 10b5-1 trading plan adopted on 11/21/2024 and was made solely to satisfy tax-withholding obligations triggered by the vesting of a restricted-stock award.

Following the transaction, the officer continues to hold 240,317 shares directly and 13,329.74 shares indirectly through the company’s 401(k) plan. A footnote notes a separate disposal of 10.29 shares between 06/09/2025 and 08/01/2025 to cover plan administrative fees. No derivative security activity was reported.

Positive

• Sale executed under a pre-established Rule 10b5-1 plan, limiting opportunistic trading concerns.
• Officer retains 240,317 direct shares, demonstrating continued equity exposure and alignment with shareholders.

Negative

• Insider disposed of 5,185 shares, which can be perceived as a modest negative signal despite tax-withholding rationale.
• Additional 401(k) share disposals marginally increase float and may raise optics of ongoing selling pressure.

Insights

Securities Analyst

TL;DR Minor tax-related insider sale; neutral signal given small size and 10b5-1 plan protection.

The reported 5,185-share sale represents a routine disposition to cover withholding taxes, not an open-market liquidity event. Execution under a pre-planned 10b5-1 program reduces concerns about information asymmetry. Post-sale holdings remain substantial at over 240k shares, suggesting ongoing alignment with shareholders. With no options exercised or large derivative changes, the filing is operationally neutral and unlikely to materially impact valuation or sentiment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fitzgerald Lindsay Clinton

(Last) (First) (Middle)

C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH

BUILDING C, SUITE 310

(Street)

ENGLEWOOD CO 80112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Advocacy & Comms Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/01/2025		S(1)		5,185	D	$1.2529(2)	240,317	D
Common Stock								13,329.74(3)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2024.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.23 to $1.29 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Between June 9, 2025 and August 1, 2025, the reporting person disposed of 10.29 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated July 25, 2025.

	/s/ E. Cabell Massey, Attorney-in-Fact	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many GEVO shares did the insider sell on 08/01/2025?

The filing reports a sale of 5,185 common shares.

What price did the GEVO insider receive for the shares?

Shares were sold at a weighted-average price of $1.2529, within a $1.23–$1.29 range.

Why were the shares sold according to the Form 4?

The sale was made to cover tax-withholding obligations triggered by restricted-stock vesting.

Does the insider still own GEVO stock after the transaction?

Yes. The officer still owns 240,317 shares directly and 13,329.74 shares indirectly via a 401(k) plan.

When was the Rule 10b5-1 trading plan adopted?

The 10b5-1 plan was adopted on November 21, 2024.